Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

Crystagen 20 mg research material

Buy Crystagen 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

Review the material specification and available batch documentation alongside the research you intend to perform.

The 20 mg label describes the amount per vial. It does not describe a solution concentration or establish equivalence to a capsule, blended preparation or another product using a similar name.

What the original research identifies

A 2014 study by Chervyakova and colleagues examined a named Crystagen preparation alongside Vilon, Timogen and R-1 in spleen-aging research. The authors described B-cell-associated activity for Crystagen, without a corresponding cell-renewal response.

The distinction matters: the peptides in that comparison did not produce identical findings. Responses assigned to the other preparations should not be treated as Crystagen results.

The study provides context for spleen-aging research. Its reported responses describe the preparations and endpoints examined by the authors.

Match the supplied material to your method

Open the Documents tab for available product files. If your experiment requires a batch report, request the document for the supplied lot and check its compound name and vial amount. Cortagen is a separate named peptide; its sequence should not be substituted for Crystagen’s.

For structure-specific protocols, record the peptide sequence, terminal groups and chemical form with the applicable analytical record. The molecular-weight reference must describe that same form.

Read identity, purity and measured-content results separately, using the methods stated in the report. For storage or handling, use the documentation for this material and request any missing information needed for the experiment.

Additional information

Applications

Laboratory research

Format

Lyophilized powder

Appearance

Lyophilized powder

Safety Information

See Documents for available product files.

COA & Documents

Independent lot testing

Crystagen 20mg Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
73186
Report number
COA12524
Date tested
November 12, 2026
Reported purity
99.79%
Labeled content
20 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for Crystagen 20mg.

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support